Literature DB >> 32324706

E-health and multiple sclerosis.

Paul M Matthews1, Valerie J Block2, Letizia Leocani3,4.   

Abstract

PURPOSE OF REVIEW: To outline recent applications of e-health data and digital tools for improving the care and management of healthcare for people with multiple sclerosis. RECENT
FINDINGS: The digitization of most clinical data, along with developments in communication technologies, miniaturization of sensors and computational advances are enabling aggregation and clinically meaningful analyses of real-world data from patient registries, digital patient-reported outcomes and electronic health records (EHR). These data are allowing more confident descriptions of prognoses for multiple sclerosis patients and the long-term relative benefits and safety of disease-modifying treatments (DMT). Registries allow detailed, multiple sclerosis-specific data to be shared between clinicians more easily, provide data needed to improve the impact of DMT and, with EHR, characterize clinically relevant interactions between multiple sclerosis and other diseases. Wearable sensors provide continuous, long-term measures of performance dynamics in relevant ecological settings. In conjunction with telemedicine and online apps, they promise a major expansion of the scope for patients to manage aspects of their own care. Advances in disease understanding, decision support and self-management using these Big Data are being accelerated by machine learning and artificial intelligence.
SUMMARY: Both health professionals and patients can employ e-health approaches and tools for development of a more patient-centred learning health system.

Entities:  

Mesh:

Year:  2020        PMID: 32324706     DOI: 10.1097/WCO.0000000000000823

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  10 in total

Review 1.  Digital tools in allergy and respiratory care.

Authors:  Elisabeth Verhoeven; Philip Rouadi; Eliane Abou Jaoude; Mohamed Abouzakouk; Ignacio Ansotegui; Mona Al-Ahmad; Maryam Ali Al-Nesf; Cecilio Azar; Sami Bahna; Lyda Cuervo-Pardo; Zuzana Diamant; Habib Douagui; R Maximiliano Gómez; Sandra González Díaz; Joseph K Han; Samar Idriss; Carla Irani; Marilyn Karam; Ludger Klimek; Talal Nsouli; Glenis Scadding; Brent Senior; Pete Smith; Anahí Yáñez; Fares Zaitoun; Peter W Hellings
Journal:  World Allergy Organ J       Date:  2022-06-23       Impact factor: 5.516

2.  Experiences, distress and burden among neurologists in Norway during the COVID-19 pandemic.

Authors:  Espen Saxhaug Kristoffersen; Bendik Slagsvold Winsvold; Else Charlotte Sandset; Anette Margrethe Storstein; Kashif Waqar Faiz
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

Review 3.  Machine Learning Use for Prognostic Purposes in Multiple Sclerosis.

Authors:  Ruggiero Seccia; Silvia Romano; Marco Salvetti; Andrea Crisanti; Laura Palagi; Francesca Grassi
Journal:  Life (Basel)       Date:  2021-02-05

Review 4.  Electronic Health Interventions in the Case of Multiple Sclerosis: From Theory to Practice.

Authors:  Maria Scholz; Rocco Haase; Dirk Schriefer; Isabel Voigt; Tjalf Ziemssen
Journal:  Brain Sci       Date:  2021-02-02

5.  Multiple Sclerosis Patient Management During the COVID-19 Pandemic: Practical Recommendations From the Portuguese Multiple Sclerosis Study Group (GEEM).

Authors:  João J Cerqueira; Ana F Ladeira; Ana M Silva; Ângela Timóteo; José Vale; Lívia Sousa; Marta Arenga; Pedro Abreu; Rui Guerreiro; João de Sá
Journal:  Front Neurol       Date:  2021-03-08       Impact factor: 4.003

Review 6.  Telemedicine as a strategic intervention for cognitive rehabilitation in MS patients during COVID-19.

Authors:  Fereshteh Ghadiri; Abdorreza Naser Moghadasi; Mohammad Ali Sahraian
Journal:  Acta Neurol Belg       Date:  2022-01-30       Impact factor: 2.471

7.  Visual Search in Naturalistic Scenes Reveals Impaired Cognitive Processing Speed in Multiple Sclerosis.

Authors:  Johannes Gehrig; Heinrich Johannes Bergmann; Laura Fadai; Dilara Soydaş; Christian Buschenlange; Marcus J Naumer; Jochen Kaiser; Stefan Frisch; Marion Behrens; Christian Foerch; Yavor Yalachkov
Journal:  Front Neurol       Date:  2022-02-14       Impact factor: 4.003

Review 8.  MSProDiscuss™ Clinical Decision Support Tool for Identifying Multiple Sclerosis Progression.

Authors:  Tjalf Ziemssen; Jo Vandercappellen; Valeria Jordan Mondragon; Gavin Giovannoni
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

9.  Behavioral practices of patients with multiple sclerosis during Covid-19 pandemic.

Authors:  Hind Alnajashi; Razan Jabbad
Journal:  PLoS One       Date:  2020-10-22       Impact factor: 3.240

Review 10.  Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease.

Authors:  Agata Matejuk; Arthur A Vandenbark; Halina Offner
Journal:  Front Neurol       Date:  2021-05-31       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.